Frieder Bauss
Penzberg, BY 82377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions.
Journal: Communications biology
Published: October 26, 2017
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
Journal: Molecular oncology
Published: May 17, 2013
Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.
Journal: Journal of bone and mineral metabolism
Published: February 04, 2013
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies.
Journal: Molecular therapy. Nucleic acids
Published: January 25, 2013
Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats.
Journal: The Journal of endocrinology
Published: November 09, 2011
Preclinical and clinical efficacy of the bisphosphonate ibandronate in cancer treatment.
Journal: Current clinical pharmacology
Published: August 12, 2008
Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat.
Journal: Journal of bone and mineral metabolism
Published: October 19, 2007
Effects of ibandronate on bone quality: preclinical studies.
Journal: Bone
Published: September 19, 2005
Ibandronate in metastatic bone disease: a review of preclinical data.
Journal: Anti-cancer drugs
Published: January 19, 2005
New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
Journal: Journal of pharmacological and toxicological methods
Published: October 22, 2003
Last Updated: 09/26/2026